HAWTHORNE, N.Y.—IBM
is building analytics clouds to help its clients make better decisions and
better use the data that is available to them.
At the launch of the IBM
Business Analytics and Optimization Services consulting practice here on
April 14, Robert JT Morris, IBM's vice president of services research, told
eWEEK, "At the infrastructure level, the pooling of data enabled by the
cloud enables us to make different decisions, and in some cases we're starting
to build analytics clouds."
For instance, IBM has created a
"biobanking cloud" for a client, where the client stores blood,
tissue and other biological material in a biobank and the cloud houses data
about the material. "So you can run tests and relate back to the
progression of diseases," Morris said.
According to the Website BioBank Central:
A biobank, also known as a
biorepository, is a place that collects, stores, processes, and distributes
biological materials and the data associated with those materials. Typically,
those "biological materials" are human biospecimens—such as tissue or
blood—and the "data" are the clinical information pertaining to the
donor of that biospecimen. A biobank can also include tissues from other
animals, cell and bacterial cultures, and even environmental samples.
Morris said a biobank cloud is often a private cloud, but an IBM
partner will at a later time be making "this information available as a
public cloud."
So not only has IBM delivered a
biobanking cloud, but also a clinical trials cloud, which "allows people
to pool data," Morris said. "And by putting it all into a cloud we
can avoid situations like Vioxx," the arthritis pain drug that drug maker
Merck pulled from the market because of concerns about risks of heart attack
and stroke, he said.
Morris said IBM has delivered cloud
environments that focus on the ability to analyze and store data, and also
clouds that focus only on analytics.
"As far as we're concerned, a cloud has to have
three attributes: It has to be shared, network-delivered and managed,"
Morris said.